Published 1 month ago

Nutra Pharma Corp. Reaches Settlement with SEC - Nutra Pharma (OTC:NPHC)

Summary by Ground News

Nutra Pharma Corp. reached a settlement with the U.S. Securities and Exchange Commission. Erik Deitsch a/k/a Rik Deitsch has tendered his resignation as Chairman and CEO of Nutra Pharma Corp effective March 19th. The Company's former CEO, Dr. Michael Flax, will resume this position effective immediately.

0 Articles

All

Left

Center

Right

Benzinga

Nutra Pharma Corp. Reaches Settlement with SEC - Nutra Pharma (OTC:NPHC)

CORAL SPRINGS, Fla., March 22, 2024 (GLOBE NEWSWIRE) -- Nutra Pharma Corporation (OTC:NPHC), ("Nutra Pharma" or the "Company") reached a settlement with the U.S. Securities and Exchange Commission ("SEC") earlier this week. On March 19, 2024, the United States District Court for the Eastern District of New York in SEC v. Nutra Pharma Corporation, Erik Deitsch a/k/a Rik Deitsch, and Sean Peter McManus, Case No. 1:18-cv-05459-JS (E.D.N.Y.), appr…

1 month ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.